Diagnosis of MEN2 typically involves a combination of clinical evaluation, family history, and genetic testing. Blood tests may be conducted to measure levels of calcitonin (a marker for MTC) and catecholamines or metanephrines (markers for pheochromocytoma). Imaging studies such as ultrasound, CT scans, or MRI may also be used to detect tumors in the endocrine glands.
